DR Healthcare


To date, no similar non-pharmacological health product relieves the pain of migraine as this anti-migraine device does.

The effectiveness of MIGRACALM® is backed by:

1.- The evaluation of its clinical neurological mechanism and its palliative therapeutic use against migraine done by the Autonomous University of Barcelona's College of Medicine and the Valle Hebrón University Hospital of Barcelona, from the conclusions of which we present the following excerpts:

"...in terms of clinical forecast and/or prediction scientifically based on evidence from diagnosis and therapeutic evaluation in vasomotor headaches, it is reasonable to infer the therapeutic use and benefit of the MIGRACALM® headband as a palliative method against migraine with clinical, neurological, medical and legal criteria from health assistance, this being able to relieve, stop and/or prevent the progression of throbbing hemicranial pain anatomically located in areas that are vascularly dependent on the temporal arteries..."

"... predictable therapeutic action during the early phases of casuistically verified migraine symptoms make it possible to qualify and clinically consider MIGRACALM® as a health product with an active therapeutic palliative effect on migraine, of an efficient clinical effect when used alone or in combination with other therapeutic procedures... " .

2.- The clinical trial conducted by prestigious neurologists, who attest to the importance of exerting pressure on the superficial temporal arteries to relieve the pain produced by migraine.

3.- Numerous publications by diverse specialists in relation to the mechanism of the product, citing some of them due to the proximity of their publication in time and the accessibility of the scientists attesting.

4.- The market study conducted throughout the year 2007 among persons suffering from migraine to test the effectiveness of the product, its concept, its image, and, in particular, its tolerance and use by migraine patients.


Neurologists Yousef Hmaidan and Carlo Cianchetti have demonstrated the effectiveness of applying pressure to the superficial temporal arteries to alleviate the pain caused by a migraine attack. Their study, entitled "Effectiveness of a prolonged compression of scalp arteries on migraine attacks" reveals this to be the case. It was published in the Journal of Neurology, volume 253, number 6, in June 2006.

94 out-patients (71 women and 23 men) aged between 8 and 62 years, with an average age of 21 years, suffering from migraine with no aura phase, according to the IHS criteria, had their migraines studied, having first been informed of the aim and the compression technique and having voluntarily accepted to undergo it.

The aim of the study was to demonstrate that "... slight compression of the superficial temporal artery can alleviate a migraine attack and a cluster headache..."

   "... The intensity of the pain which had occurred during a period ranging from a few minutes to a few hours, was moderate in 58 cases and severe in 36 cases. Some patients had used analgesics or triptans at the onset of the pain, but it had not brought them any relief, or the relief had been insufficient..."

According to the trial, "the temporal artery was compressed using firm digital pressure against the zygomatic arch in front of the tragus and 1-2 cm below that. The arteries were located by feeling for the pulse using the fingers..."

   "...When the pain was prevalent in the anterior part of the head, compression of the superficial temporal artery or arteries began..."

   "...The compression of the first artery was immediately halted if initial relief from the pain was felt, otherwise it was kept up for 3 minutes..."

» An important result:

"In total, 68% of the patients got significant or full and lasting relief from the pain; with 90% of attacks experiencing moderate pain (2). The arteries, in particular the temporal superficial arteries, were often sensitive when compressed..."

As regards the possible side effects, the trial revealed that "...There were no side effects seen."

The trial also included a fake test using the "placebo effect", which revealed that the pressure was only effective when applied to the superficial temporal artery.

   "In the last 32 patients, fake compression was applied 1 cm in front of the temporal artery, as a control. After the fake compression, we proceeded to the real compression of the artery... the fake compression never resulted in reducing the pain."

Conclusion of the study:

"Prolonged compression (more than three minutes) of the superficial temporal arteries is frequently effective in the reduction or elimination of the pain caused by a migraine".

"The possibility of achieving substantial relief or a cessation of pain with this procedure would seem to be of relevance in the treatment of migraine attacks, making it possible to prevent the need for drugs or reduce their use."

Facebook Migracalm
Share this page
Bookmark and Share

MIGRACALM® alleviates migraine pain by putting pressure on the superficial temporal arteries.
| Site map | Legal notice |  Credits |  Webmaster |
© DR Healthcare España, S.L.
All rights reserved.